Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
Stopped early
Conditions studied: Age-related Macular Degeneration, Diabetic Retinopathy, Hypertensive Retinopathy, Retinal Vein Occlusion, Retinal Artery Occlusion
In brief
The purpose of this study is to determine whether phase variance optical coherence tomography (PV-OCT), a software-based optical coherence tomography(OCT) image processing technology, can be used to generate angiographic images of the retinochoroidal vasculature that are comparable to those produced by fluorescein angiography (FA), the current gold standard diagnostic test.
Key facts
- Study ID
- NCT01717937
- Run by
- University of California, San Francisco
- People needed
- 10
- Starts
- 2013-02-01
- Expected to finish
- 2013-06-01
- Last updated by the study team
- 2014-09-04
Who can join
Age: 13 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with suspected or established retinovascular disease who are going to undergo FA as part of their usual clinical evaluation.
- Patients must be age 13 or above.
- Patients must be able to speak and understand the English language in order to provide informed consent.
You may not qualify if…
- Any patients who are unwilling to participate or provide informed consent.
- Any patients who are pregnant at the time of enrollment.
- Any patients with ocular media opacities which prevent clear evaluation of the fundus by either FA or OCT.
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.